Monoamine oxidase B inhibitors and antidepressants
Monoamine oxidase B inhibitors (e.g. selegiline and rasagiline)
NICE suggest that clinicians should:
- not normally offer SSRIs inhibitors
- offer mirtazapine, trazodone, mianserin or reboxetine
Reference:
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.